Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Coeptis Therapeutics Inc. (COEP) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Coeptis Therapeutics Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1819663.
Total stock buying since 2021: $0.
Total stock sales since 2021: $0.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 0 | $0 | 1,200,000 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-11 | 0 | $0 | 1,200,000 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-11-16 | Mehalick David (CEO and President) | Sale | 1,200,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of COEP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Coeptis Therapeutics Inc. (symbol COEP, CIK number 1819663) see the Securities and Exchange Commission (SEC) website.